Valeo Financial Advisors, LLC Repligen Corp Transaction History

Valeo Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$165.87 - $220.95 $14,264 - $19,001	-86 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$180.37 - $226.26 $541 - $678	-3 Reduced 3.37%	86 $17,000
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $740 - $1,032	-5 Reduced 5.32%	89 $17,000
Q2 2020 Jul 20, 2020	BUY	$94.33 - $140.48 $471 - $702	5 Added 5.62%	94 $12,000
Q1 2020 Apr 13, 2020	SELL	$84.96 - $109.14 $254 - $327	-3 Reduced 3.26%	89 $9,000
Q4 2019 Jan 24, 2020	BUY	$73.84 - $93.08 $6,793 - $8,563	92 New	92 $9,000
Q1 2018 Apr 12, 2018	SELL	$30.92 - $37.27 $6,184 - $7,454	-200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $7,395 - $9,212	200	200 $8,000

489

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.18B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.